Skip to Content

Glycopyrronium Bromide

In some countries, this medicine may only be approved for veterinary use.

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AB02,R03BB06

CAS registry number (Chemical Abstracts Service)

0000596-51-0

Chemical Formula

C19-H28-Br-N-O3

Molecular Weight

398

Therapeutic Category

Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)

Chemical Names

1,1-dimetyl-3-hydroxypyrrolidinium bromide α-cyclopentylmandelate (WHO)

3-(α-Cyclopentylmandeloyloxy)-1,1-dimetylpyrrolidinium bromide (BAN)

3-Hydroxy-1,1-dimetylpyrrolidinium bromide α-cyclopentylmandelate (USP)

Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimetyl-, bromide (USP)

Foreign Names

  • Glycopyrronii bromidum (Latin)
  • Glycopyrroniumbromid (German)
  • Glycopyrronium (bromure de) (French)
  • Bromuro de glicopirronio (Spanish)

Generic Names

  • Glycopyrrolate (OS: USAN)
  • Glycopyrronium (OS: DCF)
  • Glycopyrronium Bromide (OS: BAN, JAN)
  • AHR 504 (IS)
  • NVA 237 (IS)
  • UNII-V92SO9WP2I (IS)
  • Glycopyrrolate (PH: USP 41)
  • Glycopyrronii bromidum (PH: Ph. Eur. 9)
  • Glycopyrronium (bromure de) (PH: Ph. Eur. 9)
  • Glycopyrronium bromide (PH: Ph. Eur. 9)
  • Glycopyrronium Bromide (PH: BP 2018)
  • Glycopyrroniumbromid (PH: Ph. Eur. 9)

Brand Names

  • Bevespi [+ Formoterol]
    AstraZeneca, United States
  • Cuvposa
    Merz, United States
  • Enurev
    Ferrer Internacional, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Sweden; Novartis Europharm, Greece
  • Glyco-P
    Klab, Thailand
  • Glycopyrodyn
    Excelsior, Taiwan
  • Glycopyrrolate
    Amneal Pharmaceuticals, United States; Appco Pharma, United States; Aurolife, United States; Concordia, United Kingdom; Dr. Reddy's, United States; Hikma, United States; Leading Pharma, United States; Luitpold Pharmaceuticals, United States; Natco, United States; Nexgen, United States; Par Pharmaceutical, United States; Rising, United States; Santos Biotech, United States; Somerset, United States; Sun Pharma, United States; Vintage, United States
  • Glycopyrrolate [veterinary use]
    Cronus Pharma, United States
  • Glycopyrrolate Omega
    Omega Laboratories, Canada
  • Glycopyrrolate Sandoz
    Sandoz, Canada
  • Glycopyrronium Bromide
    Accord Healthcare, United Kingdom; Colonis Pharma, United Kingdom; Concordia, United Kingdom; LENIS, Slovenia; Martindale, United Kingdom; Sanolabor, Slovenia
  • Glycopyrronium Bromide and Neostigmine [+ Neostigmine]
    Concordia, United Kingdom; Martindale, United Kingdom
  • Glycopyrronium Bromide and Neostigmine Metilsulfate Max [+ Neostigmine]
    Max Health, New Zealand
  • Glycopyrronium Bromide Colonis
    Colonis, Malta
  • Glycopyrronium Bromide Macarthys
    MaCarthys, Malta
  • Glycopyrronium Bromide Martindale
    Martindale Pharmaceuticals, Cyprus
  • Glycopyrronium Bromide Max
    Max Health, New Zealand
  • Glycopyrroniumbromid Accord 200 μg/ml
    Accord Healthcare, Austria
  • Glycostigmin [+ Neostigmin]
    Takeda, Finland
  • Glykopyrroniumbromid Accord
    Accord Healthcare, Sweden
  • Hospira Glycopyrrolate
    Pfizer, Australia
  • Panthero
    Farmanova, Turkey
  • Riarify [+ Beclometasone, + Formoterol]
    Chiesi Farmaceutici, Netherlands
  • Robinul
    Aspen, New Zealand; Aspen Pharmacare, Australia; Biosyn, Germany; Casper Pharma, United States; Concordia, United Kingdom; Eumedica, Belgium; Meda, Denmark; Meda, Norway; Meda, Sweden; Pharmacare, South Africa
  • Robinul 0.2mg
    Chiesi Pharmaceuticals, Austria; Eumedica, Luxembourg
  • Robinul Forte
    Casper Pharma, United States
  • Robinul V [veterinary use]
    Vetoquinol, France
  • Robinul-Neostigmine [+ Neostigmine]
    Eumedica, Belgium; Eumedica, Luxembourg; Meda, Denmark; Meda, Norway; Meda, Sweden; Sintetica, Switzerland
  • Robinul-V [veterinary use]
    Zoetis, United States
  • Seebri
    Beijing Novartis Pharma Co., Ltd., China; Novartis, Argentina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Ireland; Novartis, Japan; Novartis, Lithuania; Novartis, Latvia; Novartis, Macedonia; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis Europharm, Cyprus; Novartis Europharm, Romania; Novartis Europharm, Tunisia; Novartis Farmaceutica, Spain; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Sunovion, United States; Novartis Singapore, Singapore
  • Seebri 44 Mikrogramm
    Novartis Pharma, Germany
  • Seebri 44mcg
    Novartis, Hungary; Novartis, Luxembourg; Novartis Europharm, Austria
  • Seebri 50mcg
    Novartis, Israel; Novartis, Oman; Novartis Pharma, Switzerland
  • Seebri Breezehaler
    Novartis, Estonia; Novartis, Indonesia; Novartis Pharma, Peru
  • Sialanar
    BCM, Estonia; Proveca, United Kingdom; Proveca, Lithuania; Proveca, Sweden
  • Sibry
    Novartis Pharma, Russian Federation
  • Tovanor
    Gebro, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Greece
  • Trimbow [+ Formoterol, + Beclometasone]
    Chiesi, Belgium; Chiesi, Germany; Chiesi, Denmark; Chiesi, Estonia; Chiesi, United Kingdom; Chiesi, Norway; Chiesi, Romania; Chiesi, Slovakia; Chiesi Farmaceutici, Sweden; Chiesi Farmaceutici S.p.A., Greece; Chiesi Pharma, Finland; Chiesi Pharmaceuticals, Netherlands
  • Trimbow 87μg/5μg/9μg [+ Formoterol, + Beclometasone]
    Chiesi Farmaceutici, Austria
  • Trydonis [+ Beclomethasone, + Formoterol]
    Chiesi Pharmaceuticals, Netherlands
  • Ultibro [+ Glycopyrronium Bromide]
    Novartis, Denmark
  • Ultibro [+ Indacaterol]
    Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Czech Republic; Novartis, Estonia; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Japan; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis Europharm, Greece; Novartis Europharm, Romania; Novartis Europharm, Slovenia; Novartis Europharm Limited, Latvia; Novartis Farmaceutica, Spain; Novartis Pharma, Peru; Novartis PHarma Services Inc., Serbia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Novartis Singapore, Singapore
  • Ultibro 110/50 [+ Indacaterol]
    Novartis Pharmaceuticals, Australia
  • Ultibro 110mcg/50mcg [+ Indacaterol]
    Novartis, Oman; Novartis Pharma, Switzerland
  • Ultibro 85 µg/43 µg [+ Indacaterol]
    Novartis, Hungary; Novartis Europharm, Austria
  • Ultibro 85 Mikrogramm/43 Mikrogramm [+ Indacaterol]
    Novartis Pharma, Germany
  • Ulunar [+ Indacaterol]
    Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Sweden; Novartis Europharm, Greece; Rovi, Spain; Sanfer, Mexico; UCB Pharma, Germany
  • Utibron [+ Indacaterol]
    Sunovion, United States
  • Vagolate
    AHPL, India
  • Xoterna [+ Indacaterol]
    Ferrer Internacional, Spain; Gador, Argentina; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Greece

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
USPPharmacopoeia of the United States
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide